Business Description
Cyclezyme AB
ISIN : SE0020975852
Compare
Compare
Traded in other countries / regions
CYCLE.Sweden IPO Date
2023-12-22Description
Cyclezyme AB is a Sweden-based company that has developed an enzymatic platform focused on producing enzymes for green biochemical processes. This platform utilizes biotechnological methods to identify and improve enzymes capable of converting e.g. PET-based plastic materials for new building blocks. The company enables careful experiments and analyses of the behavior of different enzymes in the breakdown of e.g. PET material. The company refines its enzymes and also optimizes the processes for plastic recycling by combining experimental data with data analysis.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.03 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Book Growth Rate | 544.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 26.43 | |||||
| 9-Day RSI | 36.5 | |||||
| 14-Day RSI | 41.1 | |||||
| 6-1 Month Momentum % | -7.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.13 | |||||
| Quick Ratio | 6.13 | |||||
| Cash Ratio | 5.6 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -3.28 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -33.77 | |||||
| ROA % | -28.93 | |||||
| ROIC % | -73.69 | |||||
| ROC (Joel Greenblatt) % | -787.07 | |||||
| ROCE % | -30.79 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 2.79 | |||||
| Price-to-Tangible-Book | 5.32 | |||||
| EV-to-EBIT | -5.77 | |||||
| EV-to-EBITDA | -5.82 | |||||
| EV-to-FCF | -3.26 | |||||
| Price-to-Net-Current-Asset-Value | 5.84 | |||||
| Price-to-Net-Cash | 6.6 | |||||
| Earnings Yield (Greenblatt) % | -17.35 | |||||
| FCF Yield % | -27.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cyclezyme AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.972 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 41.1 | ||
| 14-Day ATR (kr) | 0.932217 | ||
| 20-Day SMA (kr) | 7.355 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (kr) | 3 - 18.9 | ||
| Shares Outstanding (Mil) | 2.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cyclezyme AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cyclezyme AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cyclezyme AB Frequently Asked Questions
What is Cyclezyme AB(XSAT:CYCLE)'s stock price today?
The current price of XSAT:CYCLE is kr6.60. The 52 week high of XSAT:CYCLE is kr18.90 and 52 week low is kr3.00.
When is next earnings date of Cyclezyme AB(XSAT:CYCLE)?
The next earnings date of Cyclezyme AB(XSAT:CYCLE) is 2025-02-28.
Does Cyclezyme AB(XSAT:CYCLE) pay dividends? If so, how much?
Cyclezyme AB(XSAT:CYCLE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers